Menu
← Oncology Approval Tracker
FDA DECISION ·
Pemetrexed Injection (Sandoz)
pemetrexed · Sandoz
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Pemetrexed injection for labeled nonsquamous NSCLC regimens including initial pembrolizumab plus platinum in metastatic disease without EGFR or ALK aberrations, and cisplatin combination treatment for malignant pleural mesothelioma.
LAMPGEN ANALYSIS
Why it matters
The approval adds a product-specific injectable option for established pemetrexed treatment settings.
What research teams should watch
Verify the precise product, permitted partners, supplementation, renal function, and preparation steps.
PRIMARY RECORDS